Dopaminergic Therapy for Anhedonia (DTA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dopaminergic Therapy for Anhedonia (DTA), covering 2024-12-16 to 2024-12-16. Get the full timeline:
Most recent: Clinical Trial Update: DTA (Dopaminergic Therapy for Anhedonia) Study [Phase 4]